// App-Quantinova.ai

P1-18-14 : Use of pertuzumab in combination with taxanes for HER2+ metastatic breast cancer: Analysis of U.S. electronic health records

Researchers

Presenter

  • Letizia Polito

Principal Investigators

  • Jinjoo Shim

  • Yolande Du Toit

  • Thy Do

  • Adam Knott

  • Thibaut Sanglier

Medical Centers

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

Locations

  • Switzerland

  • United Kingdom

Companies

  • F. Hoffmann-La Roche

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Pertuzumab

  • taxane

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved